Forest settles Namenda patent fight with licenses

Forest Laboratories and Merck KGaA said Thursday they have settled a patent lawsuit with companies they sued over the drug Alzheimer's drug Namenda, granting 10 generics makers licenses to produce the drug in 2015. Report